Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
NCT ID: NCT04557423
Last Updated: 2025-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
797 participants
INTERVENTIONAL
2021-04-08
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HPV Self-test to Increase Cervical Cancer Screening in Asian Women
NCT04612660
Cervical Cancer Screening Intervention Among Korean American Women
NCT02594826
Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement
NCT06577220
Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening
NCT00977392
Cervical Cancer Self-Collection for Southeast Asian Immigrant and Refugee Women
NCT05286749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim 2: Examine mediators of participation. The investigators will examine both individual- and social/environmental-level factors associated with participation across both programs. It is hypothesized that higher levels of perceived self-efficacy, lower levels of embarrassment, and fewer barriers will be associated with higher rates of participation in both conditions. Further, it is hypothesized that women in the HPV self-sampling program will report greater self-efficacy, less embarrassment, and fewer barriers compared to women in the clinic-based program.
Aim 3: Assess the relative cost-effectiveness of HPV self-sampling vs. clinic-based screening. The investigators will conduct an incremental cost-effectiveness analysis from a societal perspective incorporating trial-based direct medical and participant-borne costs associated with HPV self-sampling vs. clinic-based screening. It is hypothesized that the self-sampling program will be less costly to implement and achieve a higher participation rate.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Evidence-Based Intervention
Culturally appropriate educational intervention focused on cervical cancer screening, with navigation assistance provided.
Community-Based Education
A previously evaluated educational intervention delivered in community settings. Includes culturally- and linguistically-appropriate materials.
Navigation to Screening
Community health educators provide navigation assistance to access clinic-based cervical cancer screening.
HPV Self-Sampling
Previously tested evidence-based intervention (i.e. culturally appropriate educational intervention focused on cervical cancer screening, with navigation assistance provided). Participants will also receive a self-sampling kit.
Community-Based Education
A previously evaluated educational intervention delivered in community settings. Includes culturally- and linguistically-appropriate materials.
Navigation to Screening
Community health educators provide navigation assistance to access clinic-based cervical cancer screening.
HPV Self-Sampling
An HPV self-sampling kit will be provided for home-based collection of cervical samples. Samples will be sent for analysis of HPV subtypes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Community-Based Education
A previously evaluated educational intervention delivered in community settings. Includes culturally- and linguistically-appropriate materials.
Navigation to Screening
Community health educators provide navigation assistance to access clinic-based cervical cancer screening.
HPV Self-Sampling
An HPV self-sampling kit will be provided for home-based collection of cervical samples. Samples will be sent for analysis of HPV subtypes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* are 30-65 years of age
* are overdue for cervical cancer screening (e.g., no cytology-based screening within the past 3 years; no hrHPV testing either alone or in combination with cytology in the past 5 years)
Exclusion Criteria
* had a hysterectomy with removal of the cervix
* have a compromised immune system (e.g., known HIV)
* unable to provide informed consent
30 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Temple University
OTHER
Fox Chase Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carolyn Fang, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolyn Y Fang, PhD
Role: PRINCIPAL_INVESTIGATOR
Fox Chase Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Temple University Lewis Katz School of Medicine
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-1058
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.